Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
First Opinion
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Trending
Eli Lilly headquarters
FDA approves Lilly diabetes drug that analysts expect to…
FDA approves Lilly diabetes drug that analysts expect to be a big seller
Dolly the sheep was birthed by cloning
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
BiotechClawMachine_Illustration_MollyFerguson_051122
When biotech acquisitions spike, early-stage startups are prime targets,…
When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
Recommended
Eli Lilly headquarters
FDA approves Lilly diabetes drug that analysts expect to…
FDA approves Lilly diabetes drug that analysts expect to be a big seller
Pharmalot Coming/Going STILL
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: Aspen may close South Africa Covid vaccine plant…
Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists…

Recommended Stories

Biotech

Police reports detailing Seagen CEO’s arrest raise questions about biotech’s response

By Damian Garde

Biotech

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

By Allison DeAngelis

Special Report

From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy

By Megan Molteni